Brief: Collegium Reports Q4 And Full-Year 2021 Financial Results

Collegium Pharmaceutical

24/02/2022 22:25

Feb 24 (Reuters) - Collegium Pharmaceutical Inc  COLL.O :
    * COLLEGIUM REPORTS FOURTH QUARTER AND FULL-YEAR 2021
FINANCIAL
RESULTS
    * Q4 LOSS PER SHARE $0.73
    * SEES 2022 TOTAL REVENUES ARE EXPECTED IN RANGE OF $315
MILLION
TO $330 MILLION
    * Q4 EARNINGS PER SHARE VIEW $1.04, REVENUE VIEW $81.6
MILLION --
REFINITIV IBES DATA
    * FY2022 REVENUE VIEW $411.5 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX722DQ2 
Further company coverage:  COLL.O 

 ((Reuters.Briefs@thomsonreuters.com;))